Company Filing History:
5 out of 6 
3 out of 893 
1 out of 1 Years Active: 1979-2022
Title: Shabtay Dikstein: Innovator in Ophthalmic Treatments
Introduction
Shabtay Dikstein is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of ophthalmology, particularly in the development of innovative treatments for eye conditions. With a total of 12 patents to his name, Dikstein's work has the potential to improve the quality of life for many individuals suffering from eye-related issues.
Latest Patents
Dikstein's latest patents focus on eye drops designed for the treatment of irritation not due to infection. One notable patent describes a method for treating irritation or damage to corneal or conjunctival epithelial cells, especially in cases of severe Sjögren's syndrome. This method involves applying a topically aqueous solution of glycerol with a concentration greater than 1% (w/v), with a preferred concentration of 2.5% (w/v). Remarkably, this treatment remains effective even in instances of very low tear formation, and its efficacy cannot be solely attributed to the known humectant effect of glycerol.
Career Highlights
Throughout his career, Shabtay Dikstein has worked with various organizations, including Resdevco Research and Development Company. His innovative approaches and dedication to research have positioned him as a key figure in the development of new ophthalmic treatments.
Collaborations
Dikstein has collaborated with notable individuals in the field, including Raphael Mechoulam and Naphtali Lander. These partnerships have further enriched his research and contributed to the advancement of his inventions.
Conclusion
Shabtay Dikstein's contributions to ophthalmology through his innovative patents demonstrate his commitment to improving eye health. His work continues to pave the way for new treatments that can significantly benefit patients worldwide.